"We offer the complete spectrum of diagnostics and treatment of all ear, nose, throat and allergy care. In addition, we offer the full range of facial plastic surgery, dermatology and minimally invasive cosmetic procedures."

During the past decade, Sacramento ENT conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sacramento ENT" #1 sponsor was "Intersect ENT" with 6 trials, followed by "Optinose US Inc." with 2 trials sponsored, "Accentia Biopharmaceuticals" with 1 trials sponsored, "Arrinex, Inc." with 1 trials sponsored and "Autifony Therapeutics Limited" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sacramento ENT" #1 collaborator was "Advance Research Associates" with 1 trials as a collaborator, "Ochsner Health System" with 1 trials as a collaborator, "Pearl Pathways" with 1 trials as a collaborator and "Sacramento Ear, Nose & Throat" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sacramento ENT" are "Chronic Sinusitis" (8 trials), "Chronic Rhinosinusitis" (2 trials), "Nasal Polyposis" (2 trials), "Acute Otitis Externa" (1 trials) and "Age-Related Hearing Loss" (1 trials). Many other conditions were trialed in "Sacramento ENT" in a lesser frequency.

Most popular intervention types in "Sacramento ENT" are "Drug" (10 trials), "Device" (4 trials), "Procedure" (4 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "S8 Sinus Implant" (3 trials), "Mometasone furoate nasal spray" (2 trials), "OPN-375" (2 trials), "AUT00063" (1 trials) and "Balloon Sinus Dilation Alone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sacramento ENT" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Sacramento ENT". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Sacramento ENT, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sacramento ENT, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".